Matches in SemOpenAlex for { <https://semopenalex.org/work/W2776824650> ?p ?o ?g. }
- W2776824650 endingPage "93" @default.
- W2776824650 startingPage "81" @default.
- W2776824650 abstract "New polymeric biomaterials and nanomedicines targeting cancer cells are highly required because of their potential clinical applications. Gene therapy enjoys high popularity as advanced therapy due to its high specificity; however, clinical translation is scarce because the lack of efficient and safe delivery methods. Here we address the design and development of a new nanosized targeting system consisting on Cetuximab-conjugated micelles (PM) of Pluronic® F127 (F127) and Gelatin for efficient delivery of small interfering RNA (siRNA) into epidermal growth factor receptor (EGFR) overexpressing breast cancer cells. Chemical modification by carboxylation of F127 is required prior to conjugation with Cetuximab and PM development. PM presenting appropriate physicochemical features (<40 nm) and an efficiently modified surface with Cetuximab were generated. Gelatin garnished the system with the cationic groups (ζ = +30 mV) essential for the complexation of siRNA, allowing high entrapment efficiency, and an efficient gene silencing of 70% with low cytotoxicity and proper hemocompatibility. Cetuximab-functionalized PM showed higher rate of cell internalization in EGFR expressing cells than non-functionalized PM, making them a new promising tool for targeted breast cancer treatment." @default.
- W2776824650 created "2018-01-05" @default.
- W2776824650 creator A5011145523 @default.
- W2776824650 creator A5012306555 @default.
- W2776824650 creator A5035191332 @default.
- W2776824650 creator A5036959480 @default.
- W2776824650 creator A5056452725 @default.
- W2776824650 creator A5062935890 @default.
- W2776824650 creator A5069446209 @default.
- W2776824650 creator A5074768819 @default.
- W2776824650 creator A5077842503 @default.
- W2776824650 date "2018-05-01" @default.
- W2776824650 modified "2023-10-06" @default.
- W2776824650 title "Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab functionalized Pluronic® F127/Gelatin" @default.
- W2776824650 cites W1256084377 @default.
- W2776824650 cites W1533487512 @default.
- W2776824650 cites W1588088313 @default.
- W2776824650 cites W1750915624 @default.
- W2776824650 cites W1881967720 @default.
- W2776824650 cites W1972301614 @default.
- W2776824650 cites W1973438287 @default.
- W2776824650 cites W1982036268 @default.
- W2776824650 cites W1984494103 @default.
- W2776824650 cites W1997442077 @default.
- W2776824650 cites W2010047058 @default.
- W2776824650 cites W2013321528 @default.
- W2776824650 cites W2015164743 @default.
- W2776824650 cites W2020721724 @default.
- W2776824650 cites W2029289994 @default.
- W2776824650 cites W2031414973 @default.
- W2776824650 cites W2037552241 @default.
- W2776824650 cites W2038039411 @default.
- W2776824650 cites W2045730382 @default.
- W2776824650 cites W2066241206 @default.
- W2776824650 cites W2072997205 @default.
- W2776824650 cites W2092482435 @default.
- W2776824650 cites W2092738808 @default.
- W2776824650 cites W2094422309 @default.
- W2776824650 cites W2129583958 @default.
- W2776824650 cites W2132509538 @default.
- W2776824650 cites W2134413691 @default.
- W2776824650 cites W2156412017 @default.
- W2776824650 cites W2173249787 @default.
- W2776824650 cites W2331865289 @default.
- W2776824650 cites W2344850880 @default.
- W2776824650 cites W2398902220 @default.
- W2776824650 cites W2399515336 @default.
- W2776824650 cites W2518509288 @default.
- W2776824650 cites W2536575488 @default.
- W2776824650 cites W4243057422 @default.
- W2776824650 doi "https://doi.org/10.1016/j.cej.2017.12.114" @default.
- W2776824650 hasPublicationYear "2018" @default.
- W2776824650 type Work @default.
- W2776824650 sameAs 2776824650 @default.
- W2776824650 citedByCount "25" @default.
- W2776824650 countsByYear W27768246502019 @default.
- W2776824650 countsByYear W27768246502020 @default.
- W2776824650 countsByYear W27768246502021 @default.
- W2776824650 countsByYear W27768246502022 @default.
- W2776824650 countsByYear W27768246502023 @default.
- W2776824650 crossrefType "journal-article" @default.
- W2776824650 hasAuthorship W2776824650A5011145523 @default.
- W2776824650 hasAuthorship W2776824650A5012306555 @default.
- W2776824650 hasAuthorship W2776824650A5035191332 @default.
- W2776824650 hasAuthorship W2776824650A5036959480 @default.
- W2776824650 hasAuthorship W2776824650A5056452725 @default.
- W2776824650 hasAuthorship W2776824650A5062935890 @default.
- W2776824650 hasAuthorship W2776824650A5069446209 @default.
- W2776824650 hasAuthorship W2776824650A5074768819 @default.
- W2776824650 hasAuthorship W2776824650A5077842503 @default.
- W2776824650 hasConcept C101335993 @default.
- W2776824650 hasConcept C104317684 @default.
- W2776824650 hasConcept C109316439 @default.
- W2776824650 hasConcept C119056186 @default.
- W2776824650 hasConcept C121608353 @default.
- W2776824650 hasConcept C126322002 @default.
- W2776824650 hasConcept C139770010 @default.
- W2776824650 hasConcept C1491633281 @default.
- W2776824650 hasConcept C15920480 @default.
- W2776824650 hasConcept C170493617 @default.
- W2776824650 hasConcept C178790620 @default.
- W2776824650 hasConcept C185592680 @default.
- W2776824650 hasConcept C202751555 @default.
- W2776824650 hasConcept C22615655 @default.
- W2776824650 hasConcept C2778823387 @default.
- W2776824650 hasConcept C2779438470 @default.
- W2776824650 hasConcept C2779998722 @default.
- W2776824650 hasConcept C502942594 @default.
- W2776824650 hasConcept C521977710 @default.
- W2776824650 hasConcept C526805850 @default.
- W2776824650 hasConcept C530470458 @default.
- W2776824650 hasConcept C55493867 @default.
- W2776824650 hasConcept C67705224 @default.
- W2776824650 hasConcept C71924100 @default.
- W2776824650 hasConcept C96232424 @default.
- W2776824650 hasConceptScore W2776824650C101335993 @default.
- W2776824650 hasConceptScore W2776824650C104317684 @default.
- W2776824650 hasConceptScore W2776824650C109316439 @default.